Case In Point | Uncategorized
At PathAdvantage, advancing women’s health care remains our core objective. Key to achieving that? Emily Gaston M.D. and her passion and advocacy for women’s health.
She is board-certified in anatomic and clinical pathology and specializes in...
Case In Point | Uncategorized
Syphilis. Speaking as a pathologist, it is time we looked at this disease through the lens of modern medicine with a clear-eyed view. There is a dangerous misconception that syphilis is a relic of the past, an obsolete condition — a disease of top hats,...
Case In Point | Uncategorized
As associate medical director and director of clinical pathology at PathAdvantage, Richard Hopley, M.D., is at the forefront of our patient-centered approach and cutting-edge testing.
Board-certified in both anatomic and clinical pathology, his education...
Case In Point | Uncategorized
At PathAdvantage, we're excited to announce the release of the eighth edition of The Bug Book, a critical resource for clinicians treating gynecologic-related infectious agents. This new edition includes several key updates to ensure the most accurate is at...
Case In Point | Uncategorized
Nearly 15 years ago, PathAdvantage published The Bug Book, a comprehensive resource covering vaginal health conditions, causative organisms, diagnoses and related treatments. The book answered a need for an accurate, up-to-date and easy-to-use reference...
Case In Point | General
To avoid under-diagnosis of cervical intraepithelial neoplasia (CIN) or malignancy, liberal (all 4 quadrant) colposcopic biopsies are recommended. However, pain and traumatic bleeding are powerful demotivators to both the clinician and the patient in...
PathAdvantage now offers Culture and Sensitivity testing for urinary tract infections and yeast infections. We will be happy to supply you with collection media; there is a urine cup/vial kit available for UTIs, and the same red top swab used for GBS...
Case In Point | General
One of the greatest challenges in cervical cancer screening is the sensitivity of the Pap test. The addition of high risk HPV to the Pap greatly improves sensitivity, at the cost of specificity. As described in this issue, an attempt at isolating patients at...
A Belated Happy New Year from our team to yours! With the New Year come changes to patient insurance providers and plans. PathAdvantage is ready for these changes and, as a reminder, is an in-network participating provider for ALL insurance products and...
Dr. Clarissa Herrera is the most recent addition to our team of pathologists. Specialty trained and board certified in dermatopathology, she brings her expertise in vulvovaginal disease to PathAdvantage. Outside of PA, Dr. Herrera enjoys spending time with...